Emerging studies point that acetylated peptides are acting as a critical biomarker for identification of Alzheimer's disease . Specifically , elevated concentrations of these fragments in CSF appear https://ac-peptides401767.link4blogs.com/64136856/ac-peptides-the-emerging-marker-for-neurological-dysfunction